Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129409915> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2129409915 endingPage "1445" @default.
- W2129409915 startingPage "1437" @default.
- W2129409915 abstract "OBJECTIVE: To review the occurrence and pathophysiology of myopathy associated with combined use of neuromuscular blocking agents (NMBAs) and systemic corticosteroids. DATA SOURCES: A MEDLINE search (1985 to July 1995, English language) yielded case reports and clinical studies involving myopathy or weakness associated with the use of NMBAs and/or corticosteroids. References cited in those articles were reviewed. DATA SYNTHESIS: Prolonged muscle weakness has been reported in intubated patients in the intensive care unit (ICU) who were receiving NMBAs and/or corticosteroids. Many cases involved the use of both agents in individuals with no underlying risk factors. The term “blocking agent—corticosteroid myopathy” (BACM) has been used to describe this myopathy when it develops following combined use of these agents. Features common to BACM include prolonged weakness, elevated creatine kinase concentrations, myopathic features on electromyography, normal nerve conduction and sensation, and reduced deep tendon reflexes. Muscle biopsy results vary, but tend to show type 1 and/or 2 fiber atrophy without inflammation. Some recently reported cases revealed thick myosin myofilament loss, which is consistent with findings in denervated rat muscle after exposure to corticosteroids. Two small prospective studies reported that 36–50% of mechanically ventilated patients receiving either one or both drugs developed prolonged weakness. CONCLUSIONS: NMBAs and corticosteroids alone have both been reported to cause myopathy in patients in the ICU. When coadministered, these agents appear to confer an even greater risk of myopathy; the exact pathology is not understood. Concomitant use of NMBAs and corticosteroids should be avoided if possible. Guidelines for cautious use and careful monitoring are suggested when combined use is deemed necessary." @default.
- W2129409915 created "2016-06-24" @default.
- W2129409915 creator A5065199397 @default.
- W2129409915 creator A5078486104 @default.
- W2129409915 date "1996-12-01" @default.
- W2129409915 modified "2023-09-27" @default.
- W2129409915 title "Acute Myopathy Associated with Combined use of Corticosteroids and Neuromuscular Blocking Agents" @default.
- W2129409915 doi "https://doi.org/10.1177/106002809603001213" @default.
- W2129409915 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8968457" @default.
- W2129409915 hasPublicationYear "1996" @default.
- W2129409915 type Work @default.
- W2129409915 sameAs 2129409915 @default.
- W2129409915 citedByCount "38" @default.
- W2129409915 countsByYear W21294099152012 @default.
- W2129409915 countsByYear W21294099152014 @default.
- W2129409915 countsByYear W21294099152016 @default.
- W2129409915 countsByYear W21294099152017 @default.
- W2129409915 countsByYear W21294099152019 @default.
- W2129409915 crossrefType "journal-article" @default.
- W2129409915 hasAuthorship W2129409915A5065199397 @default.
- W2129409915 hasAuthorship W2129409915A5078486104 @default.
- W2129409915 hasConcept C126322002 @default.
- W2129409915 hasConcept C141071460 @default.
- W2129409915 hasConcept C142724271 @default.
- W2129409915 hasConcept C2775934546 @default.
- W2129409915 hasConcept C2776277131 @default.
- W2129409915 hasConcept C2776418732 @default.
- W2129409915 hasConcept C2776988050 @default.
- W2129409915 hasConcept C2777300911 @default.
- W2129409915 hasConcept C2778560516 @default.
- W2129409915 hasConcept C2778970341 @default.
- W2129409915 hasConcept C2779999465 @default.
- W2129409915 hasConcept C2780247198 @default.
- W2129409915 hasConcept C2910841738 @default.
- W2129409915 hasConcept C42219234 @default.
- W2129409915 hasConcept C71924100 @default.
- W2129409915 hasConceptScore W2129409915C126322002 @default.
- W2129409915 hasConceptScore W2129409915C141071460 @default.
- W2129409915 hasConceptScore W2129409915C142724271 @default.
- W2129409915 hasConceptScore W2129409915C2775934546 @default.
- W2129409915 hasConceptScore W2129409915C2776277131 @default.
- W2129409915 hasConceptScore W2129409915C2776418732 @default.
- W2129409915 hasConceptScore W2129409915C2776988050 @default.
- W2129409915 hasConceptScore W2129409915C2777300911 @default.
- W2129409915 hasConceptScore W2129409915C2778560516 @default.
- W2129409915 hasConceptScore W2129409915C2778970341 @default.
- W2129409915 hasConceptScore W2129409915C2779999465 @default.
- W2129409915 hasConceptScore W2129409915C2780247198 @default.
- W2129409915 hasConceptScore W2129409915C2910841738 @default.
- W2129409915 hasConceptScore W2129409915C42219234 @default.
- W2129409915 hasConceptScore W2129409915C71924100 @default.
- W2129409915 hasIssue "12" @default.
- W2129409915 hasLocation W21294099151 @default.
- W2129409915 hasLocation W21294099152 @default.
- W2129409915 hasOpenAccess W2129409915 @default.
- W2129409915 hasPrimaryLocation W21294099151 @default.
- W2129409915 hasRelatedWork W150521510 @default.
- W2129409915 hasRelatedWork W1966930377 @default.
- W2129409915 hasRelatedWork W2026977659 @default.
- W2129409915 hasRelatedWork W2129409915 @default.
- W2129409915 hasRelatedWork W2142579616 @default.
- W2129409915 hasRelatedWork W2197931616 @default.
- W2129409915 hasRelatedWork W2406117960 @default.
- W2129409915 hasRelatedWork W2407518628 @default.
- W2129409915 hasRelatedWork W2755276906 @default.
- W2129409915 hasRelatedWork W2899688290 @default.
- W2129409915 hasVolume "30" @default.
- W2129409915 isParatext "false" @default.
- W2129409915 isRetracted "false" @default.
- W2129409915 magId "2129409915" @default.
- W2129409915 workType "article" @default.